265 related articles for article (PubMed ID: 18416219)
1. Low molecular starch versus gelatin plasma expander during CPB: does it make a difference?
Boks RH; Wijers MJ; Hofland J; Takkenberg JJ; Bogers AJ
Perfusion; 2007 Sep; 22(5):333-7. PubMed ID: 18416219
[TBL] [Abstract][Full Text] [Related]
2. Comparison of a waxy maize and a potato starch-based balanced hydroxyethyl starch for priming in patients undergoing coronary artery bypass grafting.
Sethi BS; Chauhan S; Bisoi AK; Kapoor PM; Kiran U; Rajput RS
J Cardiothorac Vasc Anesth; 2014 Jun; 28(3):690-7. PubMed ID: 24144628
[TBL] [Abstract][Full Text] [Related]
3. Effects of gelatine and medium molecular weight starch as priming fluid in cardiopulmonary bypass--a randomised controlled trial.
Yap WW; Young D; Pathi V
Perfusion; 2007 Jan; 22(1):57-61. PubMed ID: 17633136
[TBL] [Abstract][Full Text] [Related]
4. Influence of Two Colloidal Extracorporeal Primes on Coagulation of Cardiac Surgical Patients: A Prospectively Randomized Open-Label Pilot Trial.
Bethlehem I; Wierda K; Visser C; Jekel L; Koopmans M; Kuiper MA
J Extra Corpor Technol; 2014 Dec; 46(4):293-9. PubMed ID: 26357798
[TBL] [Abstract][Full Text] [Related]
5. Comparison of three plasma expanders used as priming fluids in cardiopulmonary bypass patients.
Tigchelaar I; Gallandat Huet RC; Boonstra PW; van Oeveren W
Perfusion; 1998 Sep; 13(5):297-303. PubMed ID: 9778712
[TBL] [Abstract][Full Text] [Related]
6. Hydroxyethyl starch 6%, 130/0.4 vs. a balanced crystalloid solution in cardiopulmonary bypass priming: a randomized, prospective study.
Gurbuz HA; Durukan AB; Salman N; Tavlasoglu M; Durukan E; Ucar Hİ; Yorgancioglu C
J Cardiothorac Surg; 2013 Apr; 8():71. PubMed ID: 23566712
[TBL] [Abstract][Full Text] [Related]
7. Cardiopulmonary bypass priming using a high dose of a balanced hydroxyethyl starch versus an albumin-based priming strategy.
Boldt J; Suttner S; Brosch C; Lehmann A; Röhm K; Mengistu A
Anesth Analg; 2009 Dec; 109(6):1752-62. PubMed ID: 19923501
[TBL] [Abstract][Full Text] [Related]
8. The safety and efficacy of ten percent pentastarch as a cardiopulmonary bypass priming solution. A randomized clinical trial.
London MJ; Franks M; Verrier ED; Merrick SH; Levin J; Mangano DT
J Thorac Cardiovasc Surg; 1992 Aug; 104(2):284-96. PubMed ID: 1379660
[TBL] [Abstract][Full Text] [Related]
9. A comparison of albumin, polygeline and crystalloid priming solutions for cardiopulmonary bypass in patients having coronary artery bypass graft surgery.
Scott DA; Hore PJ; Cannata J; Masson K; Treagus B; Mullaly J
Perfusion; 1995 Nov; 10(6):415-24. PubMed ID: 8747898
[TBL] [Abstract][Full Text] [Related]
10. Is 6% hydroxyethyl starch 130/0.4 safe in coronary artery bypass graft surgery?
Ooi JS; Ramzisham AR; Zamrin MD
Asian Cardiovasc Thorac Ann; 2009 Aug; 17(4):368-72. PubMed ID: 19713332
[TBL] [Abstract][Full Text] [Related]
11. Is the use of hydroxyethyl starch as priming solution during cardiac surgery advisable? A randomized, single-center trial.
Svendsen ØS; Farstad M; Mongstad A; Haaverstad R; Husby P; Kvalheim VL
Perfusion; 2018 Sep; 33(6):483-489. PubMed ID: 29199540
[TBL] [Abstract][Full Text] [Related]
12. Does a hyperoncotic cardiopulmonary bypass prime affect extravascular lung water and cardiopulmonary function in patients undergoing coronary artery bypass surgery?
Eising GP; Niemeyer M; Günther T; Tassani P; Pfauder M; Schad H; Lange R
Eur J Cardiothorac Surg; 2001 Aug; 20(2):282-9. PubMed ID: 11463545
[TBL] [Abstract][Full Text] [Related]
13. Volume replacement therapy during hip arthroplasty using hydroxyethyl starch (130/0.4) compared to lactated Ringer decreases allogeneic blood transfusion and postoperative infection.
Hamaji A; Hajjar L; Caiero M; Almeida J; Nakamura RE; Osawa EA; Fukushima J; Galas FR; Auler Junior JO
Braz J Anesthesiol; 2013; 63(1):27-35. PubMed ID: 23438799
[TBL] [Abstract][Full Text] [Related]
14. Volume replacement therapy during hip arthroplasty using hydroxyethyl starch (130/0.4) compared to lactated Ringer decreases allogeneic blood transfusion and postoperative infection.
Hamaji A; Hajjar L; Caiero M; Almeida J; Nakamura RE; Osawa EA; Fukushima J; Galas FR; Auler JO
Braz J Anesthesiol; 2013 Jan; 63(1):27-35. PubMed ID: 24565088
[TBL] [Abstract][Full Text] [Related]
15. Comparison of low molecular weight hydroxyethyl starch and human albumin as priming solutions in children undergoing cardiac surgery.
Miao N; Yang J; Du Z; Liu W; Ni H; Xing J; Yang X; Xu B; Hou X
Perfusion; 2014 Sep; 29(5):462-8. PubMed ID: 24658707
[TBL] [Abstract][Full Text] [Related]
16. A prospective randomized study of hydroxyethyl starch, albumin, and lactated Ringer's solution as priming fluid for cardiopulmonary bypass.
Sade RM; Stroud MR; Crawford FA; Kratz JM; Dearing JP; Bartles DM
J Thorac Cardiovasc Surg; 1985 May; 89(5):713-22. PubMed ID: 2581099
[TBL] [Abstract][Full Text] [Related]
17. Relevance of colloid oncotic pressure regulation during neonatal and infant cardiopulmonary bypass: a prospective randomized study.
Golab HD; Scohy TV; de Jong PL; Kissler J; Takkenberg JJ; Bogers AJ
Eur J Cardiothorac Surg; 2011 Jun; 39(6):886-91. PubMed ID: 21055963
[TBL] [Abstract][Full Text] [Related]
18. Hydroxyethyl starch versus Ringer solution in cardiopulmonary bypass prime solutions (a randomized controlled trial).
Tiryakioğlu O; Yildiz G; Vural H; Goncu T; Ozyazicioglu A; Yavuz S
J Cardiothorac Surg; 2008 Jul; 3():45. PubMed ID: 18620591
[TBL] [Abstract][Full Text] [Related]
19. Hemostatic effects of three colloid plasma substitutes for priming solution in cardiopulmonary bypass.
Tigchelaar I; Gallandat Huet RC; Korsten J; Boonstra PW; van Oeveren W
Eur J Cardiothorac Surg; 1997 Apr; 11(4):626-32. PubMed ID: 9151028
[TBL] [Abstract][Full Text] [Related]
20. [Effects of hyperoncotic cardiopulmonary bypass prime on extravascular lung water and cardiopulmonary function in patients undergoing coronary artery bypass surgery].
Jin X; Chen Z; Wang M; Lü W; Zhang W; Sun J
Zhonghua Yi Xue Za Zhi; 2014 Mar; 94(9):646-50. PubMed ID: 24842200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
